Join
Live feed
·
INSIDERFilingvia Quantisnow
LAVA Therapeutics N.V. logo

Large owner Versant Venture Capital Vi, L.P. sold $2,502,261 worth of shares (1,684,434 units at $1.49) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
LVTX· LAVA Therapeutics N.V.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LVTX (LAVA Therapeutics N.V.) and more on Quantisnow.